Alladapt Immunotherapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Alladapt Immunotherapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Open-label Extension Study of ADP101 (NCT05243719) | Alladapt Immunotherapeutics, Inc. | 2022-03-14 |
| ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults (NCT04856865) | Alladapt Immunotherapeutics, Inc. | 2021-04-20 |
Track Alladapt Immunotherapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.